2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram
Can GM detection be used as a surrogate marker for early (preemptive) therapy ?
Copeptin, a surrogate marker for vasopressin, is associated with chronic kidney disease progression in patients with diabetes mellitus (ZODIAC-33) - Media Centre | EASD
Reasons for failure of surrogate markers in predicting endpoints.... | Download Scientific Diagram
UNDERSTANDING SCIENCE: SURROGATE MARKERS | Evidence Based Training
Surrogate Markers by faysal haroun
Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity
Evaluation of a surrogate marker: validity and efficiency - Qu - 2013 - Statistics in Medicine - Wiley Online Library
Surrogate markers are not 'one-size-fits-all' | Cleveland Clinic Journal of Medicine
Information Theory–Based Surrogate Marker Evaluation from Several Randomized Clinical Trials with Binary Endpoints, Using SAS: Journal of Biopharmaceutical Statistics: Vol 18, No 2
Tympanic membrane pressure (TMP) as a surrogate marker of intracranial... | Download Scientific Diagram
Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases
PPT - Surrogate Markers and its role in the Drug Development Process PowerPoint Presentation - ID:533855
REBEL Cast Episode 1: Clinically Important Biphasic Anaphylaxis & Total Lymphocyte Count as a Surrogate Marker for CD4 - REBEL EM - Emergency Medicine Blog
Controlling HgBA1C with Medications Does not Make Diabetes Disappear - It Lowers the Surrogate Marker HgBA1C - APIM
Surrogate Endpoints and Biomarkers | Basicmedical Key
2 Review: Evaluating and Regulating Biomarker Use | Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease |The National Academies Press
Pharmacodynamic markers and surrogate endpoints are a subset of... | Download Scientific Diagram
Pulsatile energy consumption as a surrogate marker for vascular afterload improves with time post transcatheter aortic valve replacement in patients with aortic stenosis | Hypertension Research
MRI as a surrogate marker for clinical outcomes in multiple sclerosis | Personalized Management of Multiple Sclerosis
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | SpringerLink
Surrogate marker evaluation when data are small, large, or very large (Geert Molenberghs)
Surrogate endpoints: a regulatory review
